|Número de publicación||US3739402 A|
|Tipo de publicación||Concesión|
|Fecha de publicación||19 Jun 1973|
|Fecha de presentación||15 Oct 1970|
|Fecha de prioridad||15 Oct 1970|
|Número de publicación||US 3739402 A, US 3739402A, US-A-3739402, US3739402 A, US3739402A|
|Inventores||P Kahn, D Cooley, D Liotta|
|Cesionario original||Cutter Lab|
|Exportar cita||BiBTeX, EndNote, RefMan|
|Citas de patentes (4), Otras citas (6), Citada por (84), Clasificaciones (6)|
|Enlaces externos: USPTO, Cesión de USPTO, Espacenet|
United States Patent 1 Cooley et al.
[ June 19, 1973 BICUSPID FASCIA LATA VALVE  Assignee: Cutter Laboratories, Inc., Berkeley,
22 Filed: Oct. 15, 1970 21 Appl. No.: 81,064
OTHER PUBLICATIONS Surgery for Aortic Valve: Prosthesis and Heterograft by M. J. Levy et al., Surgery, Vol. 66, No. 2, pp. 313-318, August 1969.
-Surgitool Aortic Valve Prosthesis (Advertisement by Surgitool), The Journal of Thoracic & Cardiovascular Surgery, Vol. 58, No. 3, September 1969.
The Homograft Prosthesis by N. E. Shumway et al., Prosthetic Heart Valves by L. A. Brewer, Editor-in-- Chief, Charles C. Thomas, Publisher, Springfield, Illinois, pages 769-777, 1968.
Heart-Valve Replacement With 'Autologous Fascia Lata by M. l. Ionescoll et al., The Lancet, Vol. 2, Aug. 16, 1969, pages 335-338.
Technique of Mitral Valve Replacement with Autologous Fascia Lata by J. B. Flege et al., Journal of Thoracic & Cardiovascular Surgery, Vol. 54, No. 2, August 1967, pp. 222-226.
Prosthetic And Fascia Lata Valves: Hydrodynamics and Clinical Results by D. Liotta et al., Trans. Amer. Soc. Artif. lnt. Organs, Vol. XVI, April 1970, pages 244-251.
Primary ExaminerRichard A. Gaudet Assistant ExaminerRonald L. Frinks Attorney-Owen, Wickersham & Erickson and Bertram Bradley  ABSTRACT A graft-support for homograft and heterograft tissue valve implantation comprising a ring base, two struts extending from one side of the ring base and generally parallel to its axis, and a fabric layer covering the entire surface of the ring and struts. The fabric layer has a thickened portion at the apex of each strut, a second thickened portion along the top edge of the ring and a third thickened portion extending circumferentially of the ring. These thickened portions provide means for suturing the graft-support to the valve tissue and to the host heart, respectively. In one very advantageous embodiment, the ring is generally oblong in shape having a long diameter and a short diameter and the struts are disposed opposite to each other, one at each end of the oblong ring, i.e., at each end of the long diameter thereof or on a line parallel thereto.
In effecting the transplantation, animal tissue, such as fascia lata derived from the patient, is wrapped around the upstanding struts and joined at the ends by suturing to form a closed ring of tissue,and forming also two cusps thereof supported by the struts. Each cusp is then sutured at its baseto the covering at the top surface of the ring and along the sides of the struts, and a pledget of the fabric or suture is affixed around the top of the strut, the fabric thereover and the tissue to ensure coaptation of the cusps. The tissue, especially fascia lata from the patient, can also be extended to cover the side of the third thickened portion, or sewing ring, which is exposed to the ventricle so that, when the valve is emplaced, the entire ventricular surface is covered with autologous tissue. The device is then placed in the mitral valve position with struts extending into the ventricle and the host heart is sutured to the peripheral thickened flange, i.e., the third thickened portion.
12 Claims, 15 Drawing Figures PAIEMED 3.739.402
' sum 2 ur a INVENTOR. DENTON A COOLEY DOMINGO s. LIOTTA FIG, 1'] BYPAUL KAHN ATTORNEYS Pmmw 3739.402
SNEEI 3 If 3 INVENTOR. DENTON A. COOLEY DOMINGO s. LIOTTA PAUL KAHN ATTORNEYS BACKGROUND OF THE INVENTION This invention relates to a graft-support for valve transplantation into the human heart, and particularly it concerns a bicuspid device. The invention also concerns a method of effecting valve replacement, espe cially with the use of a homograft or autologous graft.
Synthesized and replacement tissue heart valves have been hitherto known to the art, and various types of such valves have been developed, both homograft and heterograft. It has been recognized that a tissue graft, e.g., using a semilunar valve as a replacement, is an advantageous means over a prosthesis because the dimensions of the natural valves are optimal and most nearly equal or approximate those of the damaged valve; after endothelialization no prosthetic material remains exposed to contact with the blood stream; and there is substantial absence of any thrombogenic surface or joint, so that the risk of complications from thrombosis and emboli is minimized. The longevity of aortic homograft valve has been well demonstrated and fresh aortic homografts have not appeared to deteriorate with time.
Homografts have also been used as mitral and tricuspid replacement valves. However, in addition to difficulty with supply, these have posed some problems also. Some have exhibited small but undesirable stagnant areas in the flow patterns. In others, the shape of the ring, generally circular, does not sufficiently closely approximate the shape of the damaged valve; and in these circular devices also the flow may be therefore somewhat restricted because of reduced diameter. Also, inasmuch as the homograft valve prostheses are mounted on a fabric covered frame at the time of surgery, it is desired to. perform this procedure in minimum time.
SUMMARY OF THE INVENTION The valve device of this invention attains the above objectives and has other advantages. Particularly, where it has an oblong ring base, it more closely approximates the shape of certain damaged valves to be replaced, i.e., in the mitral position or area. In other words, there is better anatomical conformation of the ring support to themitral annulus and of the two leaflets of the valve, to be more fully described below, in relation to the ventricular cavity than in the previously known tricuspid valve. It is a particular advantage of the bicuspid valve of this invention that two struts or prongs only extend into the ventricle, and the projection of a third prong intothe outflow track is avoided. It is a further advantage that, having a two-pronged ring provided as a base, and having a fabric cover, the fabrication of the completed, tissue-covered valve at surgery is a simpler and speedier procedure. The oblong base bicuspid valve of this invention also enables good flow of blood through a larger orifice and with lower pressure drop than is obtainable with circular base supports, since more of the mitral valve area can be occupied.
The stent or support frame of this invention comprises a rigid frame (made of metal or of rigid plastic such as Delrin, Teflon, or Nylon) including as a base a ring of plastic or metal resistant to the action of and compatible with body fluids, and such ring having two struts or prongs extending from the upper or the lower face thereof to enable formation of two cusps with later-added tissue. Preferably, the ring with struts is of metal and is machined from one piece of commercially pure titanium in order to avoid possible corrosion at metal interfaces and also to avoid casting faults in the metal. A layer of fabric is contoured to and completely covers all the surfaces of the metal base. The fabric is non-absorbent or resistant to and compatible with body fluids and is preferably knitted of yarn or fibers and sewn to conform tothe shape of the metal base frame. Tetrafluoroethylene (Teflon) fibers or yarn is especially suitable; but other suitable fabric, knitted or otherwise made, can be employed if desired. The fabric layer is provided with a first thickened portion at the apex of each strut, i.e., the end remote from the ring, a second thickened portion along the top edge of the frame, i.e., at the top of the ring and extending along the sides of the struts, and a third thickened portion, or sewing ring or flange, extending outwardly from the metal ring.
In the method of using the device of this invention, tissue, preferably autologous fascia lata, is wrapped around the support at the struts and the ends of the tissue strip are sutured together along the length of the strut. The tissue is also sutured to the second thickened portion along the top of the ring and at the sides of the struts thereby forming two leaflets of the valve. The tissue can also be extended over the sewing ring or flange and sutured thereto so that all prosthetic surfaces exposed to the ventricle are covered with homologus tissue. When emplaced in a heart, the two prongs of the stent extend from the valve seat into the ventricle at the sites of the anatomical commissures. The prongs simulate papillary muscles in reversed position, and extend only a short distance into the ventricle. The sewing ring is sutured to the annulus of the valve seat in the heart into which the valve replacement is being fitted. The operative lips of the tissue cusps or leaflets meet on a line parallel to the longitudinal center line of the base ring and can coincide with it or be offset from it.
The support ring can be used with autologous, homologous, and heterologous tissue, and, depending upon whether the ring base is oblong or circular, in any intracardiac position. It appears presently to be most advantageous when used with autologous tissue, such as a fascia lata graft taken from the patient.
BRIEF DESCRIPTION OF THE DRAWINGS The device of this invention, its method of use, and some of the objects and advantages of the invention will be illustrated by the specific description of one embodiment thereof which is set forth below, and by the annexed drawings wherein:
FIG. 1 is a plan view of a metal base or support ring according to the invention.
FIG. 2 is a side elevation view of the ring of FIG. 1.
FIG. 3 is an end view of the ring of FIGS. 1 and 2.
FIG. 4 is a perspective view of a graft-support according to the invention, comprising a metal base ring covered with knitted fabric.
FIG. 5 is a top plan view of the graft-support of FIG. 4.
FIG. 6 is a cross-sectional view through a typical fabri c-covered strut, taken on line 6-6 of FIG. 5.
FIG. 7 is a cross-sectional view through a fabriccoveredring, taken on line 77 of FIG. 5.
FIG. 8 is a side view showing a stent according to the invention in position to receive tissue and strip of tissue ready to be applied.
FIG. 9 is a top plan view of a valve replacement according to the invention showing juncture of cusps or valve leaflets.
FIG. 10 is a side view of the valve replacement of FIG. 9 showing suturing of leaflet at its base, to the underlying fabric of the ring support.
FIG. 1 1 is a perspective view of a bicuspid fascia lata valve according to this invention sutured into the mitral annulus of a heart.
FIGS. 12a, 12b, and 120 show schematically the relative shapes and relationships of the normal mitral valve, a prior art valve and the valve device of the present invention.
FIG. 13 is like FIG. 9 but shows an embodiment wherein the struts are displaced from the center line of the ring and provide one longer leaflet.
DETAILED DESCRIPTION OF THE INVENTION In one embodiment of the device of this invention, a graft-support ring base 10 is machined in one piece from commercially pure titanium, to eliminate any likelihood of corrosion at the metallic interfaces and the presence of casting faults. The ring 10 in this embodiment is generally oblong in form, having a long diameter and a short diameter, and it is provided with a pair of prongs or struts 11, 11' which are preferably disposed opposite each other at each end of the long diameter and both of which extend in the same direction from the ring base 12. The struts 11, 11' are rounded off at the top and connect with the ring base 12 at their sides through asmooth curve, thus avoiding sharp corners or abrupt turns, as shown in FIGS. 2, 3, 4, 8 and 10. A typical ring base is shown in FIGS. 1, 2, and 3. The struts extend generally perpendicularly to the plane of the ring base or can be outwardly inclined at a small angle to the perpendicular, e.g., of from 2 to 5 thereto, and each is provided with an aperture 13 near its apex. The ring base 12 is also provided with suitable apertures 27 whereby fabric cover 14 is sewn to and anchored to the ring base.
The ring base 12 is fitted with a fabric cover 14, as shown in FIGS. 4 to 8, to provide a suturing anchor and to which both the tissue and the host heart are sutured. This cover 14 is preferably a knitted fabric compatible with and resistant to attack by body fluids, for example, knitted Teflon (tetrafluoroethylene) fiber. In FIG. 4 is shown a typical knitted Teflon-covered device 15 comprising the ring base of FIGS. 1-3 and bearing the fabric cover 14. FIG. 6 shows a sectional view through a strut 11 having fabric cover 14 which is thickened at the top of strut 11 to provide a first thickened portion 16 to which later-applied tissue, especially fascia lata tissue, is sutured. As shown in FIG. 7, the fabric 14 is doubled over at the top of the base ring 12 to provide a second thickened portion 17 to which the cusps or leaflet bases of tissue as later applied are sutured. A third thickened portion 18 extends outwardly from ring base 12, suitably at an angle of from 30 to 60, preferably about 45, to the perpendicular or central axis of the ring, and provides a suturing anchor or support for fixing to the host heart when emplaced therein, as in the mitral valve position. If desired, the fabric of the sewing flange can be'partially quilted to stiffen it. Although the fabric has been described as being knitted Teflon, any other fabric, knitted, woven, felted or other can be employed which is compatible with the body flu ids and of sufficient strength.
When the base ring has been covered with the fabric cover, a rectangular piece of tissue 19, preferably autologous fascia lata, is wrapped around the prepared stent, as shown in FIGS. 8, 9 and 10 and is sutured at its ends to form a tube or a tubular tissue covering around the struts and intervening space. The tissue is sutured to the second thickened portion of fabric 14 to form two cusps or leaflets 20, 20 of the valve replacement and their upper edges 21, 21, i.e., those remote from the ring 12, lie adjacent each other to form the valve opening. The fascia lata tissue extends also over the sewing flange outer surface so that, when placed in the host heart all surfaces exposed to the ventricular cavity are of homologous tissue or of autologous tissue. A pledget of Teflon felt is wrapped around the apex of each strut, the fabric covering and the tissue thereover to ensure coaptation of the leaflets 21, 21', and is fixed in place by suturing. The valve replacement 25 is now ready for insertion into the host heart, after testing to determine that the leaflets operate properly. Such testing can be done by the method and means described in the co-pending patent application of Angel] et al. Ser. No. 726,288, filed May 3, 1968.
In the use and testing of the bicuspid valve of this invention, it has been found that the commissures during diastole separate approximately 2 millimeters, dropping the pressure gradient across the valve a little more than with prior art valve replacements and providing improved closure during systole. The anteromedial leaflet may be fabricated so that it is deeper than the lateral, thus becoming the principal leaflet during the functioning of the valve, such deeper leaflet being demonstrated in FIG. 13. In the embodiment of FIG. 13, struts 30, 30' are offset from the longitudinal center line of stent 31 and equidistant thereto, so that edges 21, 21' of leaflets 33, 33' are parallel to such center line. This has the result that one leaflet, 33, is longer or deeper than the other leaflet, 33, as described above.
FIG. 12a of the drawings shows a natural mitral valve 40 as occurring in a heart 41, having cusplets 42, 42', opening at 43. In FIG. 12b, the natural valve has been removed on line 44 and dotted line 45 indicates the shape of the circular base of the prior art, and lack of conformity can be seen. In FIG. 12c, the shape of the base 46 of the valve of the present invention can be seen to conform closely to the opening 44 in heart 41 which receives the valve replacement, cusplets 47, 47' meeting at line 48 to provide the valve opening during working of the valve.
The valve replacement 25 is inserted into the heart 41 to be treated, in a manner similar to that employed for the insertion of a prosthetic valve and to that described in the co-pending patent application of Angell et al, Ser. No. 726,288, filed May 3, 1968 and now U.S. Pat. No. 3,548,4l8. For mitral replacement No. 2-0 Tevdak sutures 35 are placed through the atrioventricular ring 36 of the patient, sixteen to twenty-two mattress sutures 35 being employed. When possible, the aorta is left unclamped and coronaries are perfused through the aortic root. If aortic cross-clamping is nec essary, local hypothermia may be employed for myocardial protection.
The sutures 35 are placed through the sewing ring 18 and valve replacement 25 is pushed gently into position being absolutely certain that struts 11, Ill slide past the atrioventricular ring 35 and lie in the ventricle. After assuring that sutures 35 are straight, they are pulled up and tied into place.
Caution is exercised in placement and orientation of valve replacement 25 in a small ventricle to prevent compromising the left ventricular outflow tract, and the device should be placed as high as possible in the mitral annulus consistent with good placement. Left ventricle and ascending aorta may be vented with a 20- gauge needle through the cardiac apex and ascending aorta.
All patients with prosthetic material exposed to he blood stream are preferably anticoagulated for 2-3 months postoperatively. With Coumadin (Warfarin sodium, Endo Laboratories, Inc.) as an anticoagulant, prothrombin times are maintained at 20 i 2 percent. Anticoagulants may be discontinued after a suitable period with the belief that the endothelialized surface will not form thrombus. Otherwise, patients can be treated as in any valve replacement, with gradually increasing activity.
The specific description and the drawings have been given for illustration only and modifications and variations can be made therein without departing from the spirit and scope of the appended claims. The ring base has been shown herein as oblong but it will be understood that a circular base ring can alternatively be used. The term oblong as used herein in the specification and claims is intended to mean a shape which is gener' ally oblong, that is, which has a long diameter and a short diameter, but wherein the corners and contours are rounded to conform more nearly to anatomical contours.
We claim: 1. A graft-support ring for a bicuspid valve for valve replacement in a damaged heart, including in combination a. a self-supporting shape-retaining frame comprising b. a rounded oblong ring having an upper face and a lower face and surrounding an oblong area having a major axis,
c. a pair of prongs extending from one of said faces and generally perpendicular to said oblong area, and being disposed on a plane parallel to said major axis and perpendicular to said area, and
d. a fabric covering compatible with body fluids contoured to said frame and completely enclosing it to provide a base for later suturing.
2. A graft-support ring as in claim 1 wherein said prongs extend from said ring approximately at the opposite ends of said major axis.
3. A graft-support ring as in claim 1 wherein said prongs are inclined outwardly at a small angle with respect to a line perpendicular to the plane of said area.
4. A graft-support ring for a bicuspid valve for use with autologous, homologous, or heterologous tissue, including in combination a. a self-supporting, shape-retaining frame comprisb. a generally oblong ring having an upper face, a
lower face, and a long diameter with a center,
c. a pair of struts extending from one of said faces and generally parallel to an axis through said cen' ter, and disposed on a plane parallel to said long diameter and perpendicular to the plane of said ring,
d. each said strut having an apex remote from said ring, and
e. a fabric covering compatible with body fluids con toured to said frame and completely enclosing it to provide a base for later suturing,
f. said covering having a first thickened portion adjacent each said apex, a second thickened portion along the surface of said ring to each said apex, and a third thickened portion extending outwardly from said ring to form a sewing flange.
5. A graft-support ring as in claim 4 wherein said metal ring and struts are machined from one piece of titanium metal.
6. A graft-support ring as in claim 4 wherein said flange extends at an angle of from about 30 to about 60 to said central axis.
7. A graft-support ring as in claim 4 wherein said struts are inclined outwardly at a small angle with respect to the axis of the ring.
8. A graft-support ring as in claim 4 wherein one of said struts is disposed on said metal ring at each end of said long diameter.
9. A bicuspid fascia lata valve for insertion into a ventricle valve opening of a heart and providing ventricleexposed surfaces, including in combination,
a. a self-supporting, shape-retaining frame comprisb. a generally oblong metal ring' having an upper face, a lower face, and a long diameter with a center,
c. a pair of prongs extending from one of said faces generally parallel to an axis through said center, and disposed on a plane parallel to said center, and perpendicular to the plane of said ring,
d. each of said prongs being disposed at each end of said plane and each said prong having an apex re mote from said ring,
e. a fabric covering compatible with body fluids contoured to and completely enclosing said frame to provide a base for suturing,
f. said covering having a first thickened portion at each said apex, a second thickened portion along said prongs and said face, and a third thickened portion extending as a sewing flange from said ring, and
g. fascia lata tissue covering said ventricle-exposed surfaces of said valve when inserted in said valve opening, and sutured to said fabric at said thickened portions.
10. A fascia lata valve as in claim 9 wherein said metal frame is machined from one piece of titanium.
11. A fascia lata valve as in claim 9 wherein said fascia lata is autologous tissue.
12. A fascia lata valve as in claim 9 wherein said struts are disposed on a plane parallel to and offset from said center line.
|Patente citada||Fecha de presentación||Fecha de publicación||Solicitante||Título|
|US3263239 *||1 Abr 1963||2 Ago 1966||Edwards Lab Inc||Aorta valve with expansible suturing ring|
|US3451067 *||16 Jun 1966||24 Jun 1969||Jordan Daniel Lazo||Heart valve|
|US3548418 *||3 May 1968||22 Dic 1970||Cutter Lab||Graft valve transplantation for human hearts and graft-support ring therefor|
|US3570014 *||16 Sep 1968||16 Mar 1971||Warren D Hancock||Stent for heart valve|
|1||*||Heart Valve Replacement With Autologous Fascia Lata by M. I. Ionescoll et al., The Lancet, Vol. 2, Aug. 16, 1969, pages 335 338.|
|2||*||Prosthetic And Fascia Lata Valves: Hydrodynamics and Clinical Results by D. Liotta et al., Trans. Amer. Soc. Artif. Int. Organs, Vol. XVI, April 1970, pages 244 251.|
|3||*||Surgery for Aortic Valve: Prosthesis and Heterograft by M. J. Levy et al., Surgery, Vol. 66, No. 2, pp. 313 318, August 1969.|
|4||*||Surgitool Aortic Valve Prosthesis (Advertisement by Surgitool), The Journal of Thoracic & Cardiovascular Surgery, Vol. 58, No. 3, September 1969.|
|5||*||Technique of Mitral Valve Replacement with Autologous Fascia Lata by J. B. Flege et al., Journal of Thoracic & Cardiovascular Surgery, Vol. 54, No. 2, August 1967, pp. 222 226.|
|6||*||The Homograft Prosthesis by N. E. Shumway et al., Prosthetic Heart Valves by L. A. Brewer, Editor in Chief, Charles C. Thomas, Publisher, Springfield, Illinois, pages 769 777, 1968.|
|Patente citante||Fecha de presentación||Fecha de publicación||Solicitante||Título|
|US4078268 *||7 Sep 1976||14 Mar 1978||St. Jude Medical, Inc.||Heart valve prosthesis|
|US4275469 *||13 Dic 1979||30 Jun 1981||Shelhigh Inc.||Prosthetic heart valve|
|US4306319 *||16 Jun 1980||22 Dic 1981||Robert L. Kaster||Heart valve with non-circular body|
|US4339831 *||27 Mar 1981||20 Jul 1982||Medtronic, Inc.||Dynamic annulus heart valve and reconstruction ring|
|US4340977 *||19 Sep 1980||27 Jul 1982||Brownlee Richard T||Catenary mitral valve replacement|
|US4343048 *||4 Ago 1980||10 Ago 1982||Ross Donald N||Stent for a cardiac valve|
|US4366581 *||2 Sep 1981||4 Ene 1983||Medical Incorporated||Elliptical suturing cuff|
|US4372317 *||22 Nov 1976||8 Feb 1983||Look International Enterprises, Inc.||Method of installing a scalp anchor for a hairpiece|
|US4441216 *||3 Dic 1981||10 Abr 1984||Shiley, Inc.||Tissue heart valve and stent|
|US4477930 *||28 Sep 1982||23 Oct 1984||Mitral Medical International, Inc.||Natural tissue heat valve and method of making same|
|US4490859 *||18 Ene 1983||1 Ene 1985||University Of Sheffield||Artificial heart valves|
|US4491986 *||13 Oct 1977||8 Ene 1985||Shlomo Gabbay||Heart valve|
|US4561129 *||11 Oct 1983||31 Dic 1985||Pro. Bio. Spe. S.R.L.||Low-profile biological bicuspid valve|
|US4605407 *||9 Ene 1984||12 Ago 1986||The University Of Sheffield||Heart valve replacements|
|US4655773 *||20 Jun 1985||7 Abr 1987||Ge. Sv. In. S.R.L.||Bicuspid valve prosthesis for an auriculo-ventricular cardiac aperture|
|US4759759 *||22 Dic 1983||26 Jul 1988||Walker David K||Bubble heart valve|
|US4851000 *||31 Jul 1987||25 Jul 1989||Pacific Biomedical Holdings, Ltd.||Bioprosthetic valve stent|
|US5488789 *||8 May 1992||6 Feb 1996||Nika Health Products Limited||Process and apparatus for the production of a heart valve prosthesis|
|US5503638 *||10 Feb 1994||2 Abr 1996||Bio-Vascular, Inc.||Soft tissue stapling buttress|
|US5554184 *||27 Jul 1994||10 Sep 1996||Machiraju; Venkat R.||Heart valve|
|US5606928 *||2 Jun 1995||4 Mar 1997||Nika Health Products Limited||Process and apparatus for the production of a heart valve prosthesis|
|US5769892 *||22 Oct 1996||23 Jun 1998||Mitroflow International Inc.||Surgical stapler sleeve for reinforcing staple lines|
|US5861028 *||9 Sep 1996||19 Ene 1999||Shelhigh Inc||Natural tissue heart valve and stent prosthesis and method for making the same|
|US6264691||23 Abr 1999||24 Jul 2001||Shlomo Gabbay||Apparatus and method for supporting a heart valve|
|US6358277 *||21 Jun 2000||19 Mar 2002||The International Heart Institute Of Montana Foundation||Atrio-ventricular valvular device|
|US6582464 *||26 Mar 2001||24 Jun 2003||Shlomo Gabbay||Biomechanical heart valve prosthesis and method for making same|
|US6610088 *||3 May 2000||26 Ago 2003||Shlomo Gabbay||Biologically covered heart valve prosthesis|
|US6755857 *||12 Dic 2001||29 Jun 2004||Sulzer Carbomedics Inc.||Polymer heart valve with perforated stent and sewing cuff|
|US6974464||2 May 2002||13 Dic 2005||3F Therapeutics, Inc.||Supportless atrioventricular heart valve and minimally invasive delivery systems thereof|
|US7247167||19 Feb 2004||24 Jul 2007||Shlomo Gabbay||Low profile heart valve prosthesis|
|US7316822||26 Nov 2003||8 Ene 2008||Ethicon, Inc.||Conformable tissue repair implant capable of injection delivery|
|US7785366||15 Nov 2007||31 Ago 2010||Maurer Christopher W||Mitral spacer|
|US7824701||25 Feb 2003||2 Nov 2010||Ethicon, Inc.||Biocompatible scaffold for ligament or tendon repair|
|US7871435||18 Ene 2011||Edwards Lifesciences Corporation||Anatomically approximate prosthetic mitral heart valve|
|US7875296||29 Nov 2007||25 Ene 2011||Depuy Mitek, Inc.||Conformable tissue repair implant capable of injection delivery|
|US7901461||5 Dic 2003||8 Mar 2011||Ethicon, Inc.||Viable tissue repair implants and methods of use|
|US8016867||28 Oct 2004||13 Sep 2011||Depuy Mitek, Inc.||Graft fixation device and method|
|US8034104 *||23 Sep 2010||11 Oct 2011||Edwards Lifesciences Corporation||Anatomically approximate prosthetic mitral valve|
|US8092525||26 Oct 2005||10 Ene 2012||Cardiosolutions, Inc.||Heart valve implant|
|US8137686||20 Abr 2004||20 Mar 2012||Depuy Mitek, Inc.||Nonwoven tissue scaffold|
|US8137702||29 Dic 2010||20 Mar 2012||Depuy Mitek, Inc.||Conformable tissue repair implant capable of injection delivery|
|US8163008||25 Feb 2008||24 Abr 2012||Heart Leaflet Technologies, Inc.||Leaflet valve|
|US8216302||28 Abr 2009||10 Jul 2012||Cardiosolutions, Inc.||Implant delivery and deployment system and method|
|US8221780||29 Jun 2006||17 Jul 2012||Depuy Mitek, Inc.||Nonwoven tissue scaffold|
|US8226715||24 Jul 2012||Depuy Mitek, Inc.||Scaffold for connective tissue repair|
|US8449561||15 Feb 2007||28 May 2013||Depuy Mitek, Llc||Graft fixation device combination|
|US8449606||14 May 2007||28 May 2013||Cardiosolutions, Inc.||Balloon mitral spacer|
|US8480730||14 May 2007||9 Jul 2013||Cardiosolutions, Inc.||Solid construct mitral spacer|
|US8486136||31 Ago 2010||16 Jul 2013||Cardiosolutions, Inc.||Mitral spacer|
|US8496970||27 Feb 2012||30 Jul 2013||Depuy Mitek, Llc||Conformable tissue repair implant capable of injection delivery|
|US8506623||10 Jul 2012||13 Ago 2013||Cardiosolutions, Inc.||Implant delivery and deployment system and method|
|US8591460||28 Jul 2009||26 Nov 2013||Cardiosolutions, Inc.||Steerable catheter and dilator and system and method for implanting a heart implant|
|US8597347||15 Nov 2007||3 Dic 2013||Cardiosolutions, Inc.||Heart regurgitation method and apparatus|
|US8637066||21 Sep 2010||28 Ene 2014||Depuy Mitek, Llc||Biocompatible scaffold for ligament or tendon repair|
|US8641775||1 Feb 2011||4 Feb 2014||Depuy Mitek, Llc||Viable tissue repair implants and methods of use|
|US8691259||16 Nov 2005||8 Abr 2014||Depuy Mitek, Llc||Reinforced foam implants with enhanced integrity for soft tissue repair and regeneration|
|US8721716||9 Sep 2011||13 May 2014||Edwards Lifesciences Corporation||Prosthetic heart valve with dissimilar leaflets|
|US8778017||14 May 2007||15 Jul 2014||Cardiosolutions, Inc.||Safety for mitral valve implant|
|US8852270||15 Nov 2007||7 Oct 2014||Cardiosolutions, Inc.||Implant delivery system and method|
|US8888844||10 Ene 2012||18 Nov 2014||Cardiosolutions, Inc.||Heart valve implant|
|US8894705||23 Abr 2013||25 Nov 2014||Cardiosolutions, Inc.||Balloon mitral spacer|
|US8895045||8 May 2012||25 Nov 2014||Depuy Mitek, Llc||Method of preparation of bioabsorbable porous reinforced tissue implants and implants thereof|
|US8979922||11 Mar 2005||17 Mar 2015||Percutaneous Cardiovascular Solutions Pty Limited||Percutaneous heart valve prosthesis|
|US20040078077 *||25 Feb 2003||22 Abr 2004||Francois Binette||Biocompatible scaffold for ligament or tendon repair|
|US20040078090 *||25 Feb 2003||22 Abr 2004||Francois Binette||Biocompatible scaffolds with tissue fragments|
|US20040092858 *||28 Ago 2003||13 May 2004||Heart Leaflet Technologies, Inc.||Leaflet valve|
|US20050038520 *||11 Ago 2003||17 Feb 2005||Francois Binette||Method and apparatus for resurfacing an articular surface|
|US20050113937 *||26 Nov 2003||26 May 2005||Francois Binette||Conformable tissue repair implant capable of injection delivery|
|US20050125077 *||5 Dic 2003||9 Jun 2005||Harmon Alexander M.||Viable tissue repair implants and methods of use|
|US20050149181 *||7 Ene 2004||7 Jul 2005||Medtronic, Inc.||Bileaflet prosthetic valve and method of manufacture|
|US20050177249 *||9 Feb 2004||11 Ago 2005||Kladakis Stephanie M.||Scaffolds with viable tissue|
|US20050187618 *||19 Feb 2004||25 Ago 2005||Shlomo Gabbay||Low profile heart valve prosthesis|
|US20050232967||20 Abr 2004||20 Oct 2005||Kladakis Stephanie M||Nonwoven tissue scaffold|
|US20120143324 *||30 Sep 2011||7 Jun 2012||BioStable Science & Engineering, Inc.||Aortic Valve Devices|
|USRE31040 *||15 Feb 1980||28 Sep 1982||St. Jude Medical, Inc.||Heart valve prosthesis|
|EP0084395A1 *||13 Ene 1983||27 Jul 1983||Martin Morris Black||Artificial heart valves|
|EP0108941A2 *||14 Oct 1983||23 May 1984||PRO.BIO.SPE. srl.||A low-profile biological bicuspid valve|
|EP0125393A1 *||29 Oct 1981||21 Nov 1984||Shiley Incorporated||Prosthetic heart valve|
|EP0276975A1 *||26 Ene 1988||3 Ago 1988||Yoel Ovil||Replacement of cardiac valves in heart surgery|
|WO1992019185A1 *||8 May 1992||12 Nov 1992||Nika Health Products Ltd||Process and apparatus for the production of a heart valve prosthesis|
|WO2005004753A1 *||9 Jun 2003||20 Ene 2005||3F Therapeutics Inc||Atrioventricular heart valve and minimally invasive delivery systems thereof|
|WO2005072654A1 *||21 Ene 2005||11 Ago 2005||Edwards Lifesciences Corp||Anatomically approximate prosthetic mitral heart valve|
|WO2005087140A1 *||11 Mar 2005||22 Sep 2005||Percutaneous Cardiovascular So||Percutaneous heart valve prosthesis|
|WO2014201384A1 *||13 Jun 2014||18 Dic 2014||The Regents Of The University Of California||Transcatheter mitral valve|
|Clasificación de EE.UU.||623/2.16, 623/900|
|Clasificación cooperativa||A61F2/2412, Y10S623/90|